Virbac points to research showing that MCTs are the most common form of skin cancer in dogs, accounting for up to 21% of skin cancer cases1.
This, says the company, means that understanding the challenges surrounding mast cell tumour diagnosis, work up (including the various prognostic panels) and treatment selection for mast cell tumour cases is vital.
The session, entitled ‘Fundamentals of Mast Cell Tumour Management’, will conclude with a review of Stelfonta, walking through cases and how to get the best results.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "We know that vets are facing webinar fatigue.
"We therefore hope that this brand new style of online learning on one of the most common canine cancers will be more engaging, whilst still delivering high quality CPD."
To register for the live event, visit: https://tinyurl.com/mct-masterclass
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Reference
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
The Disciplinary Committee heard four charges against Dr Schulze Allen.
The first charge related to the original criminal conviction in the County of San Bernardino in California dating from September 2013, where Dr Schulze Allen pleaded guilty to petty theft for which he was fined US $435 and ordered to pay a fee of US $35.
The second charge related to the fact that, on or around 3 December 2013 in a written application for restoration to the Register, Dr Schulze Allen was dishonest in representing that he did not have any cautions or criminal convictions.
The third charge related to the fact that on or around 4 December 2013 in a sworn affidavit before a Notary Public in Riverside, California, he dishonestly and falsely represented that he had, at no time, been convicted of a criminal offence in the UK or elsewhere.
The final charge was that, in an email to the RCVS in June 2016, he dishonestly and falsely represented that he had "no criminal record whatsoever".
Having found Dr Schulze Allen guilty of all four charges the Committee then considered whether the conviction rendered him unfit to practise veterinary surgery and whether the remaining charges amounted to disgraceful conduct in a professional respect.
The Committee noted that the conviction was for a minor matter but had regard to all the evidence before it and considered that as an offence of dishonesty it represented a breach of one of the fundamental tenets of the profession. It further considered that Dr Schulze Allen’s dishonesty toward the College and his completing a legal document which he knew would be relied upon by the College was conduct that fell far short of the standard expected of a member of the profession.
With regard to the final charge, the Committee considered this a "clear attempt to deliberately misrepresent the fact that he had a conviction for a criminal offence." The Committee considered that Dr Schulze Allen’s conduct had been aggravated by the fact that it was protracted and repeated over a period of time.
Ultimately the Committee considered that the conviction rendered Dr Schulze Allen unfit to practise veterinary surgery and the remaining charges amounted to disgraceful conduct in a professional respect.
Ian Green, chairing the Committee and speaking on its behalf, said: "His conduct represented a blatant disregard of the role of the RCVS and the systems that regulate the veterinary profession. The Committee also remained particularly concerned at Dr Schulze Allen’s very limited insight into his conduct."
He added: "In mitigation the Committee noted that this is not a case where harm was caused to any animals or humans. It noted that prior to these matters which are before the Committee that Dr Schulze Allen had an unblemished career and that he had been of good character. In respect of purely personal mitigation the Committee noted that Dr Schulze Allen is the main breadwinner of the family."
However, the Committee considered that Dr Schulze Allen’s conduct had fallen significantly short of standards expected of a veterinary surgeon.
Ian Green concluded: "The Committee considered that the only appropriate sanction is that of removal from the Register. Such a sanction is required to send a clear message to Dr Schulze Allen and to veterinary surgeons of the unacceptability of being dishonest to the RCVS. Such conduct undermines public confidence in the profession and fails to uphold proper standards of conduct and behaviour.
"Accordingly, the Committee has decided that removal from the Register is appropriate and proportionate in this case. The Committee will direct the Registrar to remove the respondent’s name from the Register forthwith."
Dr Schulze Allen has 28 days from the date of the decision to appeal the Committee’s decision.
The Committee’s full findings and decision is available at www.rcvs.org.uk/disciplinary.
The company says it is calling for the change after analysing the records of its consultations held during the pandemic and finding that there was a low antibiotic prescribing rate, treatments were effective and no harm was caused.
During the seven months that Vet-AI collected data, from the 1st April to the 31st October 2020, its vets held 21,383 veterinary video consultations, an analysis of which is the subject of a paper published in the RCVS Knowledge journal, Veterinary Evidence1.
78.1% of the consultations were for dogs and 21.9% for cats.
Of the vet-led video consultations completed, 3,541 had medicines prescribed during the consultation.
Some consultations required more than one prescription, which meant a total of 4,282 POM-V medications were prescribed.
Of those, Vet-AI says 0.87% reported a mild adverse effect.
Antibiotics were prescribed in 5.9% of all consultations, 99.3% of which was first line.
Vet AI says follow-up on prescribing was available in 67.7% of cases and 89.4% of all known treatment outcomes were complete or had an expected response to treatment.
Skin problems were the most common body system/disease category seen and prescribed for.
The remaining 17,482 consultations, which did not require a prescription medicine, had resolutions assigned.
They included 959 referrals to an emergency in-person veterinarian visit; 4,852 recommendations to visit a vet in-person; 4,216 alternative products recommended, 6,421 follow-up consultations with the remote veterinary team, and 219 remote laboratory tests.
Samantha Webster MRCVS (pictured right), from Joii Pet Care, said: “Given the clear evidence outlined in this report, we believe the future of veterinary medicine should include remote consultations with remote prescribing where appropriate and regulated.
"We invite the RCVS and other veterinary governing bodies to consider that there is a place for prescribing remotely on an ongoing basis for certain cases under certain conditions, such as a secure video and audio link with clinical record keeping and pharmacovigilance practice.
"A blanket ban is not appropriate with the advance of modern technology."
“Bold steps have been taken in human health, incorporating modern technologies to support both GPs and patients, to great success.
"Our industry could use these learnings to help reduce the current strain and demands on vets across the country where mental health is already a key issue due to increased pressures, under resourcing, and compassion fatigue.
“We feel it’s important to take this approach to reach as many owners and provide professional advice and appropriate treatment on pet health so that those animals that do not necessarily currently receive veterinary care do so, and to bridge the gap wanted by clients.”
The online risk checker, which is available at www.parassess.co.uk, asks pet owners a series of questions to assess their dog's risk from fleas, ticks, lungworm roundworm and tapeworm.
The test, which has been developed with parasitologists, takes a few minutes and appears to produce sensible results (not every test produces a "Danger, high risk, emergency, get to your vet NOW" result, as you might expect if this had been entirely produced bv the marketing department).
The subsequent report can then be shared with the vet to review it and make a treatment decision.
Being online, the test can be taken on a smartphone whilst in the practice waiting room, or on tablet or computer at home.
It might be worth sharing the test with your clients by email or social media, inviting them to book an appointment if their results suggest it is necessary.
To that end, Boehringer Ingelheim has produced a range of communication materials, such as waiting room displays and digital content for web, email, SMS, and social media.
For more information, contact your local Boehringer Ingelheim territory manager or phone 01344 746957 (UK) or 01 291 3985 (Ireland).
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against an Essex-based veterinary surgeon who qualified in 1969, following his undertakings firstly to request removal from the RCVS Register and secondly never apply to be restored to it.
At the hearing, which had originally been listed for seven days, Geoffrey Raymond Oliver, 68, was charged with serious professional misconduct over allegations of his inadequate treatment of two dogs and a cat (belonging to three different clients) between 2010 and 2012; inadequate record keeping; failures to deal honestly or properly with his clients; and, failure to heed advice from the RCVS Preliminary Investigation Committee about the importance of proper communication between veterinary surgeons and their clients.
However, before the Committee heard evidence on any aspect of these charges, Mr Oliver lodged his application for adjournment. The Committee therefore made no findings on the charges, and emphasised they had neither been proved against, nor admitted by, him.
The Committee noted that there had been no adverse findings against Mr Oliver during his professional career, that his practice was now closed and that he had no intention of returning to practise in the future. Should he subsequently apply to be restored to the Register, the Committee would resume its consideration of the charges, along with his breach of the undertaking.
The Committee was advised that none of the complainants in the case - which could have incurred considerable time and costs - dissented from the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "The Committee has concluded that no useful purpose would be served were it to insist on a full hearing [and it] would be a disproportionate waste of...resources [to do so]. The Committee is satisfied that [granting the adjournment application] protects the welfare of animals and...is in the public interest."
The Committee then accepted Mr Oliver's undertakings, including the removal of his name from the Register with immediate effect.
Professor Lees added: "So that he is in no doubt about the matter, the Committee reminds [Mr Oliver] that, when referring clients of his former practice elsewhere, he should be careful to avoid giving them any advice about the diagnosis or treatment of their animals."
Metacam 40 mg/ml solution for injection for cattle and horses contains 40 mg/ml of meloxicam, and is available in either 50 ml or 100 ml presentations. It is approved for subcutaneous or intravenous use in cattle, and intravenous use in horses.
Boehringer says the introduction comes on the back of a recent large-scale landmark study that found adding Metacam to standard antibiotic therapy for mastitis resulted in a greater first-service conception rate, fewer inseminations required to conceive and a higher probability of pregnancy by 120 days post-calving when compared to cows receiving antibiotic therapy alone1.
Boehringer Ingelheim’s technical manager Kath Aplin said: "By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes. This is central to efficient herd management and productivity."
The company adds that new Metacam 40 mg/ml formulation offers a lower volume dose compared to the existing 20 mg/ml presentation, giving vets more flexibility in their use of Metacam.
The Apple iPad made its UK debut last week. I queued outside the Apple shop for over 15 minutes (well, it was Salisbury, not Regent Street) on launch day to get my hands on one of the first and review it for VetSurgeon members.
For those that don't have the time for long-winded reviews, I'll come straight to the point: buy one, you won't regret it. Even if you get home and decide you have no use for a tablet computer, you could probably put it on ebay and turn a small profit. But you won't. You'll just keep finding more reasons why the iPad is an indispensable piece of kit.
I won't dwell on the technical specifications of the thing. All you really need to know is that it's a touchscreen tablet computer about the size of a small hardback, though it weighs a little more. I don't know (or care) what sort of chip it contains. Whatever it is, it's more than capable of handling the tasks the iPad is designed to do, effortlessly.
So why is the iPad a 'must have'? Because it transforms the experience of browsing the Internet, reading email etc. from being a bit of a hassle, to being as simple and quick as, er, picking up and opening a book. I think the best way to illustrate my point is to describe the uses I've found for it in the first 4 days of ownership:
BrowsingI wanted to know what's on locally for children this weekend. Normally I'd have to go and power up the computer upstairs. Not anymore. Now I just pick the iPad up off the kitchen table. It wakes instantaneously, and the browser opens at the press of a button. Incidentally, once I'd found the Sherborne Fair, it was only another couple of clicks before it was displayed on the built-in map, along with an estimated time to get there. In my case, it also makes my job easier - I can dip into the VetSurgeon and VetNurse forums much more easily when away from my desk (something I intend to be more of, from now on).
EmailNot much to say, except that once again, it's a pleasure to be able to check my email at the press of a button, rather than having to go upstairs and power up my desktop, or wait whilst my wife's interminably slow laptop gets its act together. No, the touch screen keyboard is not quite as well suited to the task as a normal keyboard. Having said that, I typed half this article on my iPad last night at very nearly the same two-handed speed as I would have on my desktop.
Read the newspaperThe Times is now available on the iPad for £9.99 per month. You just press the download button any time after 7:00am, and a few minutes later it appears on the screen. If you fall into the camp that says: 'it'll-never-catch-on-....-nothing'll-replace-the-feel-of-a-book-or-a-newspaper', I wouldn't have argued with you a week ago. Now I would. The iPad version is beautifully intuitive, and a pleasure to read. Despite a few grumbles (where is The Sunday Times?), I'll be cancelling my print subscription.
PhotographsThis is really the first viable alternative to the traditional print photograph album. And it's not just an alternative, it's a far superior way of storing and retrieving photographs. The iPad's high quality display means your pictures really leap off the screen. Its portability and ease of access mean that you might actually look at your photos and share them with others from time-to-time, rather than leaving them to gather dust in a box, or sit in an unvisited folder on your computer. I'm digitising 20 year's worth of photographs for this reason.
Other uses and appsThe list of software applications for the iPad is growing every day. Meantime, any app designed for the iPhone will also run on the iPad, though they don't make full use of the big screen. There are thousands of rather pointless apps, seemingly designed not to meet a need nobody knew they had. But amongst the rubbish, there are some genuinely useful apps out there:
A couple of minor irritations about the iPad. Currently it doesn't support the rich editing feature used by default when you post to the VetSurgeon forums, or elsewhere on the site. Fortunately, there's a quick workaround, which is to visit your VetSurgeon profile (My Account > Edit My Profile > Display Options tab) and set the Content Editor to 'Plain text'. Also, very occasionally the iPad freezes, at which point you have to press the On/Off and Home buttons together for six seconds to reset. Doubtless both these will be fixed in the next software update, due in the next month or two, I think.
The 'twitterati' has bemoaned the iPad's lack of hardware features and flexibility. There's nowhere to insert a DVD. No camera. No USB port. No card reader. But that rather misses the point. The iPad isn't a replacement for a desktop or laptop unless the only things you use a computer for are browsing and email. Anyone who wants to store and edit video, edit photographs, or create anything other than fairly basic documents or spreadsheets, still needs a bigger machine with USB ports and DVD drives galore. What the iPad does is free you from having to browse electronic media at a desk. And it does so in such user-friendly way that I'll be ordering one for my Mum (aged 62) and my grandmother (aged 92).
There are six models available. Three memory sizes: 16GB, 32GB and 64GB with either wi-fi Internet access, or wi-fi plus 3G mobile phone access. Prices from £429 to about £700 (to which you'll need to add the cost of a protective wallet). I plumped for the 64GB memory (probably overkill), wi-fi only model, on the basis that there are enough BT Openzone wi-fi hotspots now to mean I'll never be far from one.
I'm not normally one for hyperbole. But in this case, I'll forgive Mr. Jobs calling the iPad 'a magical and revolutionary product'.
It is.
The article points towards the corporatisation of the profession, with 51% of practices now owned by private equity groups and 67% belonging to a group of three practices or more, as the main driver for an increase in vets' fees of over twice the rate of inflation between 2015 and 2020.
However, what the article focuses on, which is the issue of complex and very expensive treatments for pets, is a multifactorial problem which cannot be entirely blamed on corporatisation.
At its heart lie advances in science which now allow vets to offer ever more complex treatments and diagnostics which, when used in human medicine to prolong a human life might sometimes seem expensive, but when used to prolong the life of a dog, can occasionally seem a bit bonkers.
Indeed the article does point towards over-treatment being partly driven by 'celebrity vets advocating increasingly complex surgeries'.
Then there's the fact that both parties to the transaction are often heavily invested in the idea of doing whatever can be done to save the dog: the pet owner, who has anthropomorphised their pet since they first collected it, and the vet, who's entire career has been dedicated to doing their best for the patient in their care.
Then of course there's the inflationary effect of insurance on treatment.
After all, if the animal is insured, why wouldn't you throw the kitchen sink at it?
Things are complicated by the difficulty in estimating the cost of veterinary treatment at the outset, when so much depends on the unknown outcome of diagnostic tests, the progression of disease and the success or failure of treatment. It's not like quoting for a new exhaust system.
There's also the inflationary effect of the increasingly litigious and socially litigious world we live in. It would be no surprise if veterinary surgeons have become more likely to test for everything, when the consequences of missing something is a soul-destroying trial by social media.
And finally, there's the subjective value of money.
Nevertheless, the Daily Mail has a point.
Selling any product or service is about meeting clients' and customers' needs.
If you keep increasing the price of your product range until all you can offer is a Rolls Royce, sooner or later you're going to price yourself out of the market.
One other lesson for the profession from that article: 'No comment' is not a good look for a caring profession.
Virbac has has announced the launch of Buprevet, a buprenorphine-based, injectable solution indicated for the potentiation of sedative effects of centrally-acting agents in dogs and for use in cats and dogs as part of a multimodal approach to analgesia.
Buprevet is presented in a 10 ml multi-dose bottle which can be broached up to 25 times and can be open for up to 28 days.
Sarah Walker MRCVS, Product Manager, said: "Buprenorphine is a potent, high affinity, synthetic opioid agonist which forms a key element of practice anaesthetic protocols and complements our existing anaesthetic range. Its potentiation effects means less sedation is needed in the pre-medication and in the anaesthesia, facilitating smoother recoveries with more comfortable patients."
"Buprenorphine is a tried and trusted solution for analgesia in many practices. Buprevet can be given pre-operatively to allow analgesia during and after surgery. It works effectively as part of a pre-emptive approach to analgesia, alongside products such as Inflacam and Carprox in our NSAIDs range."
The Society of Practising Veterinary Surgeons (SPVS) has published its 2014 Salaries Survey which showed that the gender pay gap has closed from 15% last year to 10.8% this.
However, the association notes that this is still slightly higher than the gap reported for all professions in the UK, so there remains work to be done.
The survey, which is the largest of its kind and drew responses from 1,878 vets, nurses, practice managers and receptionists also found that:
Peter Brown, SPVS Treasurer and author of the report comments: "The SPVS Salaries Survey is intended as a benchmark to give some indication of what is being paid as the 'going rate' rather than to advise on what employees should be paid. Having said that, we would urge all veterinary practices to continue working to ensure that equal rates of pay are given for positions of equal status. Although the gender gap has closed up, it is still too big."
The annual SPVS Salaries Survey is free of charge to SPVS members and costs £150 for non-members. For more information, call 01926 410454 or visit www.spvs.org.uk.
With fewer than 72 female Suffolk Punches remaining in the UK and fewer than 300 in the world, every female born is vital to the survival of this endangered British horse.
In 2019 Tullis Matson, owner and managing director of Stallion AI Services, saw an opportunity to use a new technological advancement in the sex sorting of equine semen to provide a lifeline to Britain’s critically endangered rare and native horses.
Tullis said: “To be able to use our reproduction expertise in this way, to help preserve an irreplaceable part of our magnificent heavy horse heritage is something we have been working towards for many years. The challenges have been great and many, but watching the birth of this beautiful, healthy filly foal was a truly magical experience."
The sex sorting project uses specialist equipment to sex sort the semen prior to insemination based on the difference in DNA content between X and Y bearing spermatozoa.
Ruby, the Suffolk Punch mare and Holbeach Iggy, the Suffolk stallion were selected and matched based on their genetics as part of a project between The Rare Breed Survival Trust and Nottingham Trent University that uses pedigree information to enable the breeding of small populations in a way that minimises the risk of inbreeding and genetic decline.
Christopher Price, Chief Executive of the Rare Breed Survival Trust, said: “This is tremendous news for anyone concerned with the conservation of our native equines. The most effective way of increasing the population size of this very rare breed is by increasing the number of fillies being born.
“The project demonstrates the viability of using new techniques for selecting female foals in order to increase the breeding population much more rapidly than could be achieved through relying on traditional methods. We hope it will prove to be a model for more projects in the future.”
Baycox Iron Injection is indicated for the concurrent prevention of clinical signs of coccidiosis (such as diarrhoea) in neonatal piglets on farms with a confirmed history of coccidiosis caused by Cystoisospora suis, and the prevention of iron deficiency anaemia.
Professor Nicole Kemper, Director of the Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour at the University of Veterinary Medicine Hannover in Germany said: "Piglets go through intense handling in their first days of life. While this is done to give them a better start to life and protect them from disease, it can also cause a lot of stress. Measures to reduce the need for piglet handling can make an important contribution to enhancing piglet well-being in the farrowing pen."
Octavio Orlovsky Eckhardt, Head of Species Marketing Swine at Animal Health, Bayer said: "A combination therapy that can effectively address these concerns with reduced handling can make a real difference for pig health and well-being.
"At the same time, farmers and workers can benefit from the reduced labour. For example, on a 1,000 sow farm, the reduced complexity is estimated to save up to one full work day every month."
For more information on Baycox Iron Injection, contact your local Bayer Animal Health representative.
BVA President Sean Wensley said: "The UK's decision to leave the European Union will have a significant impact on matters of interest to the veterinary profession, particularly in relation to regulation, education, and workforce planning, but also in terms of animal welfare, research, surveillance, and animal movements.
"BVA will work hard to ensure the voice of the veterinary profession is heard during the negotiation and discussions that will now begin, in order to secure the best possible outcomes for our profession and for animal health and welfare in the UK. The Vet Futures report provides an excellent summary of issues we need to consider in those discussions, and the Vet Futures Action Plan, due to be launched at the Vet Futures Summit on 4 July, outlines key initiatives that we need to take forward, albeit with revised timelines while the full impact of Brexit is determined.
"BVA will retain an outward looking and inclusive perspective through our relationships with international partners, including the Federation of Veterinarians for Europe (FVE), Commonwealth Veterinary Association (CVA) and World Veterinary Association (WVA) to ensure the UK veterinary profession continues to influence and engage on cross border issues such as disease surveillance, veterinary medicines and antimicrobial resistance."
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
The independent practice, which was set up in 2010 by husband and wife team Richard and Sophie Aylett, will be a hard act to follow because not only did they achieve awards in all three areas for which they were eligible, but they were marked as "Outstanding" in all three.
For farm practices, the five possible awards are: Team and Professional Responsibility, Client Service, Advisory/Consultancy Service, Diagnostic Service and In-Patient Service. However, as an ambulatory first opinion farm animal practice, Meadows Farm Vets Ltd was only eligible for the first three awards.
Comments from the PSS Assessor included:
"Clinical governance was developing well in the practice. The recording of all surgeries in a file but also in an easy to see chart on the wall, colour coded re follow up was an excellent idea."
"Infection control & biosecurity were taken very seriously and all vehicles were immaculately clean & tidy."
"There was great support provided to new graduates and a comprehensive induction for new team members."
"The resources for farmers including written reports, training meetings, general meetings and comprehensive monthly newsletters were the best I have seen in a farm practice."
"The use and monitoring of a surgical checklist for all surgical procedures was impressive."
Practice Principal Sophie Aylett said: "We are extremely proud to have been recognised by the Royal College for our modern and innovative approach to farm practice. It has been a real team effort in working towards these Awards and we are very excited to be the first farm animal practice to have achieved all three Awards.
"To be marked as “Outstanding” in all three areas is testament to the great team of competent, confident and content vets and staff who are Meadows Farm Vets Ltd."
For the research, 326 recruited veterinary practices examined 812 cats and 662 dogs using a standardised flea inspection protocol in April and June 2018.
Fleas were collected, the species identified, and pooled flea samples from each host were analysed for the presence of pathogens using PCR and sequence analysis.
Overall, fleas were found on 28.1% of cats and 14.4% of dogs.
Unsurprisingly, over 90% of the fleas on both cats and dogs were our dear old friends, Ctenocephalides felis.
The PCR results found that at least 14% of the samples were positive for at least one pathogen, and 11.3% were positive for Bartonella spp (35 from cats, 4 from dogs), a pathogen which was identified as a risk to veterinary professionals and others with direct animal contact in a 2010 research paper2.
Entomologist Professor Richard Wall from the University of Bristol said: "Fleas are the most clinically important ectoparasites of dogs and cats worldwide.
"Rising levels of pet ownership, climate change and globalisation are increasing the importance of a detailed understanding of the endemicity and prevalence of flea-borne pathogens. This requires continued surveillance to detect change.
"The results have shown the high numbers of cats and dogs that still carry fleas and the relatively high prevalence of Bartonella spp found in the samples provided, which is of significant concern for the health of the pet, pet owner and veterinary practice staff."
Nicola Barclay, Senior Product Manager at MSD Animal Health said: "The Big Flea Project results demonstrate the ongoing need for pet owners to understand the importance of flea prevention, particularly with the implications of infestation for human and animal health.
"It’s particularly important at this time of the year as the weather is getting warmer and infestation is more likely to occur.
"Our national launch today has been designed to raise awareness amongst pet owners and encourage them to seek advice from the veterinary practice.
"Building awareness of the risks of fleas to practices and pet owners is also at the forefront of our ongoing campaign."
The service will be available to veterinary practices that use more than £250/€300 of Royal Canin urinary diets per year.
The company has enlisted the support of an independent laboratory to carry out an infrared spectroscopy analysis of the stones, in order to make a quantitative and qualitative assessment of their composition. Royal Canin says that by appreciating the mineral-type in all layers, the best dietary recommendation can be made.
Lee Danks, Royal Canin’s Veterinary Scientific Support Manager, said: "Managing cat and dog urolithiasis can be challenging. This valuable service will improve practices’ diagnostic capacity, enabling a better understanding of a patient’s condition and a much more individualised approach to treatment and long-term prevention."
Royal Canin says there are many complex and interacting contributors to urinary stone formation1. Dietary modifications can influence urine pH, the concentration of minerals within the urine and most critically, urine turn-over through the bladder2. The many interactions between promotors and inhibitors of urolithiasis highlight just how critical a tailored nutritional approach can be to the long-term health of urinary patients.
Royal Veterinary College research, published in the journal PLOS ONE, has revealed that 1 in 4 cases of Diabetes Mellitus in domestic cats are caused by excess secretion of pituitary growth hormone.
According to the researchers, this is much more common than previously thought. Furthermore, they say that cats with this condition are easily misdiagnosed as having primary (type 2) diabetes mellitus but do not respond to the standard treatment to that condition, resulting in increased morbidity and ultimately leading to euthanasia on welfare grounds.
Researchers collected data between 2003 and 2011 on cats treated at vet practices across the UK, to estimate the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date and look how easy this is to recognise.
Findings revealed that the presence of Diabetes Mellitus in 1 in 4 domestic cats can be explained by hypersomatotropism, which is caused by a pituitary benign tumour and can be effectively treated by one operation in specialist centres.
However only 24% of clinicians who submitted samples suspected that this was the case, as most hypersomatotropism cats did not display typical signs, instead displaying symptoms indistinguishable from cats with primary (type 2) Diabetes Mellitus. This suggests that hypersomatotropism screening should be considered when treating diabetic cats.
Lead researcher, Dr Stijn Niessen from the Royal Veterinary College, said: "It has been common practice to automatically suspect a cat with Diabetes Mellitus to be suffering from a form of diabetes akin to human type 2. The current study suggests that this is an oversimplification. Approximately one in four of assessed diabetic cats were actually found to be suffering from hypersomatotropism-induced Diabetes Mellitus, which requires specific treatment and manifests itself very differently as it develops.
"Interestingly, only a small proportion of clinicians reported they strongly suspected acromegaly to be present on the basis of the clinical picture. These data therefore highlight the need for veterinarians working with the spontaneously diabetic cat to consider routinely screening for the presence of hypersomatotropism-induced Diabetes Mellitus, given the significant clinical consequences of its presence.
"Should the hypersomatotropism be diagnosed and treated with one operation, most cats will enter a state of diabetic remission. If it remains undiagnosed, diabetic cats tend to be difficult to regulate glycaemically which often results in euthanasia, or in the long-term, they will suffer from other growth hormone-induced negative conditions such as heart disease, as well as central nervous system problems."
Evaluation of serum fructosamine was offered free of charge for all diabetic cats attending any veterinary practice in the UK from October 2003 till April 2011. Veterinary surgeons were asked to record clinical data about the patient, including age, breed, gender, current body weight, current administered insulin dose and whether they clinically suspected acromegaly/ hypersomatotropism. Diabetic cats were screened using serum total insulin-like growth factor-1, followed by further evaluation through pituitary imaging and/ or histopathology.
In total, 1221 diabetic cats were screened; 319 (26.1%) had a blood IGF-1 suggestive of hypersomatotropism. Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95%, suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8%.
The paper also suggests that although great opportunities exist for comparative research between primary (type 2) diabetes in cats and humans, researchers should exercise caution in light of these new findings.
Stijn added: "The similarities between feline and human type 2 diabetes emphasise great opportunities for valuable comparative research benefiting all species into this major disease, which is fast becoming a global epidemic. However our latest research proves that there is a need for more regular hypersomatotropism screening, to identify the root cause of diabetes in domestic cats before samples are used, so as not to corrupt results."
The survey, which received over 1300 responses, found that the problem is more noticeable amongst locum vets (69% have worked when they’ve not felt well enough) and employees (64%) but is also an issue amongst partners and the self-employed (57%). It’s more common for vets in clinical practice (65%) than in non-clinical roles (51%). In all of these sectors over half of vets reported working when they were unwell.
18% of the vets surveyed said they do not take sick leave because they feel uncomfortable doing so. This is more common amongst younger vets (25% of under 35s compared to 19% of 35-54-year olds, and 8% of over 55s) and female vets (21% compared to 11% of male vets).
The main reasons given for not taking time off when sick are concerns about the impact on colleagues and worries about "letting the team down". One respondent said: "Because I would leave the practice understaffed and the remaining vets would have to work a lot harder and longer as a result." Another said: "Being ill is not an option. The practice is short staffed."
Members also reported a perceived culture of working through sickness. One said: "The veterinary industry on the whole has a 'phone in dead' policy ie don't call in sick!" and another said: "[I] feel that I am judged for taking time off, even when I lost my voice and was unable to consult."
A small number of responses (36 of the 450 vets who commented) mentioned that they did not receive sick pay or only received limited sick pay, so they avoided taking sick leave for financial reasons.
The BVA is reminding all vets that they have a legal right not to attend work when they aren’t well enough do so and that any concerns should be discussed with managers. The free BVA legal helpline is available to members to provide further guidance on taking sick leave.
BVA President Daniella Dos Santos said: "We know that veterinary workplaces are under enormous pressure from staff shortages, and none of us wants to feel like we are letting our colleagues down, but presenteeism only stores up more problems for the future.
"Working when you are ill puts your own health and wellbeing at risk longer term and can also put your colleagues, clients and patients under your care at risk.
"It’s particularly worrying that some of our colleagues feel pressure to work when they feel unwell, especially younger members. As a profession we have made huge steps forward in recognising the issues around mental health and supporting one another and being physically unwell should be the same.
“Anyone who is concerned should speak to their manager and remember that BVA members can always get free advice and support via the BVA legal helpline. Ultimately, it’s important to create a workplace culture that supports the entire veterinary team to prioritise their own physical and mental health."
Photo: Javier Brosch / Shutterstock
The company says Dormazolam works in synergy with other induction agents to provide an extended duration of anaesthesia without adversely affecting the quality of recovery 2,3,5.
Benzodiazepines are commonly incorporated into anaesthetic regimens to alleviate issues seen with the administration to ketamine alone2,3,4, including inadequate muscle relaxation2,3,4, anaesthesia not lasting long enough2 and induction failure2.
Despite the issues caused by the sole use of ketamine, it remains the primary anaesthetic induction agent of choice for more than 90% of equine vets2.
Dechra Brand Manager Emma Jennings said: “Using Dormazolam as part of an equine anaesthesia protocol will give optimal general anaesthetic conditions every time, including a rapid onset of action1.
"Anaesthetic co-induction with ketamine and midazolam has been shown to provide a superior quality of anaesthesia compared to ketamine alone3 and midazolam is equally as effective as diazepam when used as a co-induction agent alongside ketamine4. It also cuts down on the number of ketamine ‘top-up’ doses required compared to using ketamine3 alone.
"Additional benefits include no clinically significant differences in cardiopulmonary function1 or recovery times1 between midazolam and diazepam and it can be mixed in the same syringe as ketamine for ease of use4.”
Emma added: “The introduction of Dormazolam provides an exciting new option for equine vets. It delivers enhanced anaesthetic and surgical conditions by improving anaesthetic induction quality2,3,4 and giving better surgical relaxation scores2,3,4. It also reduces involuntary movements because, as a co-induction agent, midazolam only causes minimal cardiovascular and pulmonary depression2,4.”
Dormazolam is available in a 20 ml vial. It has a shelf life of four years and a broached shelf life of 28 days.
For more information, visit: www.dechra.co.uk/therapy-areas/equine/anaesthesia/analgesia.
References:
Lead author Professor Clare Rusbridge, Chief of Neurology at Fitzpartick Referrals, conducted the study because of a lack of clarity on the recognition and diagnosis of the clinical signs associated with CM as opposed to syringomyelia (SM).
CM is an abnormality in the skull, making it smaller, and impacting on the brain to alter the flow of cerebrospinal fluid; this results in pain and a collection of fluid pockets within the spinal cord. These fluid pockets are commonly known as SM and over time can cause irreversible damage to a dog’s spinal cord. However it is not clear whether signs of pain in affected dogs are due to CM or SM or both.
To try to rectify this, Clare studied the medical records of all the cavalier King Charles spaniels diagnosed with CM-associated clinical signs presenting to her at Fitzpatrick Referrals over a five year period. She documented the historical and examination findings and related them to the MRI findings, including presence and size of the SM.
She found common signs in all dogs were vocalisation, spinal pain (neck, middle or lower back), reduced activity, reduced stairs or jumping ability, aversion to being touched or groomed, altered emotional state (described as being more timid, anxious, withdrawn or aggressive) and sleep disturbance.
A tendency to rub or scratch at the head or ears was common but was more likely in dogs with small or no SM suggesting that this may be a sign of head discomfort associated with CM. Head and ear rubbing was not associated with the presence of material within the middle ear (a condition which is also common in this breed and often given the acronym PSOM).
The only signs that were specific to SM were phantom scratching, scoliosis (twisted spine) and weakness and these were only present when the SM was large (at least 4mm wide).
Clare says this study is important because it suggests that CM alone is a cause of pain in many dogs. The aim now is to use the information gained in this study to develop a questionnaire to determine risk of CM and monitor the response to clinical signs.
Photo: Charlie on a bad day
The Disciplinary Committee of the Royal College of Veterinary Surgeons last week directed that the name of a man who had been illegally practising as a veterinary surgeon in the North West of England be removed from the RCVS Register, having found him guilty of fraudulent registration.
In March 2008, Russell Lewis Oakes had been charged with fraudulent entry onto the Register of Veterinary Surgeons, on the basis that he had (either (A) knowingly, or (B) unknowingly) submitted a fake degree certificate and letter of 'good standing' from Murdoch University, Australia. Mr Oakes agreed that the hearing could proceed in his absence provided the Committee confined itself to consideration of charge B alone.
The hearing commenced on 18 April 2008, but the Committee decided to adjourn, as Mr Oakes was also subject to a police investigation which required that the hearing be held in private. The Committee felt that it was in the public interest for an open hearing to take place in respect of both charges at a later date. Mr Oakes' bail conditions prevented him from practising as a veterinary surgeon at this time.
On 16 October 2009, Mr Oakes was convicted at Liverpool Crown Court, on a guilty plea, of a substantial number of offences, including those under consideration by the Committee: he was sentenced on 11 January 2010 to two years in prison.
The RCVS Disciplinary Committee's hearing resumed and concluded on 5 February 2010. Mr Oakes was not present.
The Committee was provided with evidence from RCVS staff regarding the registration process, and received statutory declarations from representatives at Murdoch University. The latter confirmed that signatures on the certificate submitted by Mr Oakes were fake and that there had never been a student with his name at the University. Furthermore, a letter purporting to be one of support from Professor Edwards of Murdoch University contained text he would not have written and was signed with a false signature.
The Committee was also provided with evidence from equine veterinary surgeon Seamus Miller, who had become suspicious of Mr Oakes' qualifications and membership of the College. He outlined incidents which had cast doubt on Mr Oakes' competence. Mr Miller's complaint had initiated enquires which led to the charges against Mr Oakes by the College, and the Committee recorded its commendation of Mr Miller, and his colleagues.
Having found that Mr Oakes knowingly submitted fraudulent registration documents, the Committee was bound, under Sections 14 and 16 of the Veterinary Surgeons Act 1966, and paragraph 17 of the 2004 Rules, to direct that his name be removed from the Register.
Alison Bruce, Chairman of the Disciplinary Committee, said: "Even if it retained any discretion by virtue of Section 16 of the Act in respect of sanction, the Committee would have had no hesitation in directing Mr Oakes' name to be removed from the Register in this case. This was a deliberate and dishonest offence by a man without the necessary qualifications to practise as a veterinary surgeon, and it had the effect of exposing members of the public to his fraud, and their animals to harm."
The College has revised its registration procedures in the light of this case, and now requests that all registrants produce original copies of certificates and letters of 'good standing' at the registration ceremony.
EthyCalm is sprayed directly on the skin, or, for more fractious patients, can be applied with a swab.
Invicta says that unlike other products the effect is instant and EthyCalm leaves no residue on the skin surface.
The improved product, EthyCalm Plus, contains 50% more product (good for over 100 applications) and incorporates a new 'on-off' switch for easier application. It is also now packed in a 'no-roll' case to protect from damage.
Rob Watkins, Managing Director of Invicta, said: "EthyCalm has been an incredibly popular product with nurses and vets. As a small company we always listen to our customers and have taken the opportunity to incorporate suggestions for improvement. The result is EthyCalm Plus which offers significant enhancement over the original product".
EthyCalm Plus is available from veterinary wholesalers and for a limited time the price has been held at £25 each.
The raw pet food poster gives owners guidance on how to handle and prepare their pet’s meal when feeding a commercial raw pet food. The guinea pig one gives guidance on what owners need to feed their guinea pig to ensure good health and well-being. It is also available to download from: www.pfma.org.uk/the-importance-of-hay-poster-guinea-pigs.
The PFMA will be giving away free copies of both the posters, alongside a range of other fact sheets and posters, at the London Vet Show.
The Association is also offering veterinary surgeons the chance to win a £100 high street shopping voucher by taking part in its annual survey focusing on health and feeding trends, which can be done here: www.surveymonkey.com/r/PFMALVS19
The survey closes on Sunday 17th November.